deucravacitinib
bms
['psoriasis', 'deucrava', 'deucra', '$bmy']
$bmy u.s. food and drug administration approves sotyktu (deucravacitinib), oral treatment for adults with moderate-to-severe plaque psoriasis stock news alerts in bio
Over 500 members. DM us for our premium stock alerts.